Brittany Craiglow

Brittany Craiglow, MD is an Adjunct Associate Professor in the Department of Dermatology at Yale School of Medicine, specializing in pediatric dermatology with particular expertise in alopecia areata and hair disorders. Her clinical and research work focuses on developing and evaluating novel therapeutic approaches for hair loss conditions, especially in pediatric populations.

Dr. Craiglow received her BA from Yale University in 2004, followed by her MD from Yale University School of Medicine in 2009. She completed her residency at Yale-New Haven Hospital in 2013 and a fellowship at Yale University School of Medicine in 2014. She is board-certified in both Dermatology and Pediatric Dermatology by the American Board of Dermatology.

Her research interests center on alopecia areata pathophysiology and treatment, with emphasis on JAK inhibitors like baricitinib and ritlecitinib, combination therapies including oral minoxidil, and the psychosocial impact of hair loss. Dr. Craiglow's work spans clinical trials, epidemiological studies, and development of assessment tools like the Severity of Alopecia Tool (SALT).

Analysis of her recent publications reveals a strong focus on pediatric alopecia treatments, baricitinib efficacy and safety, novel therapeutic combinations, and comprehensive assessment of disease severity and patient quality of life. Her research frequently addresses both clinical outcomes and psychological impacts of hair loss conditions.

Dr. Craiglow collaborates extensively with leading researchers including Keith Choate, Leonard Milstone, and Geliang Gan, contributing to numerous multicenter clinical trials and global research initiatives in dermatology. Her work appears in top dermatology journals including the Journal of the American Academy of Dermatology, British Journal of Dermatology, and Pediatric Dermatology.